Fulcrum Therapeutics (FULC) Other Non Operating Income (2018 - 2019)
Fulcrum Therapeutics' (FULC) quarterly Other Non Operating Income came in at $7000.0 in Q4 2019, little changed year-on-year from $7000.0 in Q4 2018, and little changed on a QoQ basis from $7000.0 in Q3 2019.
Fulcrum Therapeutics (FULC) Other Non Operating Income (2018 - 2019) Analysis & Trends
Fulcrum Therapeutics (FULC) has 2 years of Other Non Operating Income data on file, last reported at $7000.0 in Q4 2019.
- On a quarterly basis, Other Non Operating Income changed 0.0% year-over-year to $7000.0 in Q4 2019; TTM through Dec 2019 was $29000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $29000.0, down 92.6% from the prior year.
- Other Non Operating Income for Q4 2019 stood at $7000.0, roughly flat from $7000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for FULC reached as high as $8000.0 in Q2 2018 and fell as low as $7000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fulcrum Therapeutics | 286.57 Mn | 286.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 8,000.00 |
| Dec 31, 2018 | 7,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Jun 30, 2018 | 8,000.00 |